Mehmet Cizmeci

Dr. Mehmet Nevzat Cizmeci is a staff neonatologist at SickKids and Associate Professor of pediatrics at the University of Toronto. Cizmeci graduated from Istanbul University Medical School in 2004 and after completing his pediatric residency and neonatology fellowship training in 2013, he started a research fellowship in neonatal neurology and PhD in neuroscience at Utrecht University in 2017. He joined the neonatal neurology team at SickKids as a clinical fellow in 2019 and received the Royal College Subspecialty Fellow Excellence Award. He then completed a 2-year clinical/research fellowship as the Dr. Karen Pape Fellow in Neuroplasticity at SickKids and received his PhD degree in clinical and experimental neuroscience in 2022. Dr. Cizmeci has a strong commitment to research and teaching.

Research

Cizmeci's research interests are optimizing treatment in neonatal hemorrhagic brain injury as well as understanding trajectories of neuronal plasticity, neuromodulation, and accurately predicting childhood neurodevelopmental outcomes.

Education and experience

• 2020–2022: Dr. Karen Pape Fellowship in Neuroplasticity, University of Toronto, Toronto, Canada
• 2017–2022: PhD, Clinical and Experimental Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
• 2019–2020: Neonatal Neurology Clinical Fellowship, University of Toronto, Toronto, Canada
• 2017: Neonatal Neurology Research Fellowship, Utrecht University, Utrecht, The Netherlands
• 2010–2013: Neonatology Fellowship, Turgut Özal University, Ankara, Turkey
• 2004–2010: Pediatric Residency, Istanbul Bakırköy Children’s Teaching Hospital, Istanbul, Turkey
• 1998–2004: MD, Istanbul University, Istanbul, Turkey Residency & Fellowship 

Achievements

• 2019: Royal College, CanMEDS Subspecialty Fellow Excellence Award, University of Toronto, The Hospital for Sick Children, Toronto, Canada

1. [Principal Author]. Cizmeci MN, Groenendaal F, Liem KD, van Haastert IC, Benavente-Fernández I, van Straaten HLM, Steggerda S, Smit BJ, Whitelaw A, Woerdeman P, Heep A, de Vries LS; ELVIS study group. Randomized Controlled Early versus Late Ventricular Intervention Study (ELVIS) in Posthemorrhagic Ventricular Dilatation: Outcome at 2 Years. Journal of Pediatrics 2020 Nov; 226: 28-35. 
2. [Principal Author]. Cizmeci MN, de Vries LS, Ly LG, van Haastert IC, Groenendaal F, Kelly EN, Traubici J, Whyte HE, Leijser LM. Periventricular Hemorrhagic Infarction in Very Preterm Infants: Characteristic Sonographic Findings in the Current Era and Association with Neurodevelopmental Outcome at 2 Years. Journal of Pediatrics 2020 Feb; 217: 79-85.
3. [Principal Author]. Cizmeci MN, Khalili N, Claessens NHP, Groenendaal F, Liem KD, Heep A, Benavente-Fernández I, van Straaten HLM, van Wezel-Meijler G, Steggerda SJ, Dudink J, Išgum I, Whitelaw A, Benders MJNL, de Vries LS; ELVIS study group. Assessment of Brain Injury and Brain Volumes after Posthemorrhagic Ventricular Dilatation: A Nested Substudy of the Randomized Controlled ELVIS Trial. Journal of Pediatrics 2019 May; 208: 191-197.

Relevant pages